Capnat (Capecitabine) — Patient Guide (Australia)
Capnat is a medicine containing capecitabine, an oral anti-cancer medicine used to treat certain solid tumours. This guide explains what Capnat does, how it works in the body, typical uses, how to take it safely, important food and medicine interactions, and what to expect during treatment. It is written for general patient information and does not replace advice from your treating healthcare team.
1) Basic product information
| Category | Information |
|---|---|
| Medicine name | Capnat (capecitabine) |
| Type | Oral chemotherapy (antimetabolite; fluoropyrimidine) |
| How it is taken | By mouth in tablets (timed dosing schedules vary by regimen) |
| Common forms | Tablets (strengths vary; your label/pharmacist can confirm) |
| Therapeutic area | Various cancers, often as part of combination therapy |
Important: Always follow the schedule and dose exactly as provided by your healthcare team. Your treatment plan may differ depending on the cancer type, stage, and whether other medicines are used alongside Capnat.
2) How Capnat works (mechanism of action)
Capecitabine is a prodrug—meaning it is converted in the body to its active form. It belongs to the fluoropyrimidine class of medicines.
- Conversion to active drug: Capecitabine is metabolised in the body to 5-fluorouracil (5-FU).
- Cell-targeting effect: 5-FU interferes with how rapidly dividing cancer cells make DNA and RNA.
- Why it can be selective: The conversion process is influenced by tumour-related enzymes, so higher active drug levels may occur in tumour tissue compared with normal tissues.
In practical terms, Capnat helps slow or stop tumour growth by disrupting DNA/RNA synthesis in cancer cells.
3) Pharmacokinetics (what the body does with Capnat)
Pharmacokinetics describes how the body absorbs, processes, and eliminates a medicine. Capecitabine undergoes several conversion steps before producing 5-FU and related metabolites.
- Absorption: Capecitabine is absorbed through the gastrointestinal tract after oral dosing.
- Metabolism: It is converted in the liver and other tissues, with further metabolism producing active metabolites (including 5-FU).
- Distribution: The active metabolites distribute throughout the body and act on rapidly dividing cells.
- Elimination: Metabolites are primarily cleared through the kidneys and excreted in urine.
Kidney function matters: Because elimination involves the kidneys, your healthcare team may adjust dosing or monitor more closely if you have reduced kidney function.
4) Typical use in cancer care
Capnat is used in a range of cancers and may be used:
- As monotherapy (alone) in some situations
- In combination with other anti-cancer medicines in many regimens
- Before or after surgery (depending on the specific cancer plan)
The exact treatment goal (for example, reducing recurrence risk after surgery or controlling advanced disease) depends on the diagnosis and stage.
5) Indications (where Capnat is used)
In Australia, capecitabine is used for certain solid tumours. Your doctor may prescribe Capnat for indications such as:
- Breast cancer: In some regimens and settings, including combination approaches.
- Colorectal cancer: Used in metastatic and other settings.
- Gastric (stomach) and gastro-oesophageal cancers: In selected treatment plans.
- Other related solid tumours: Based on clinical guidelines and individual factors.
Note: Indications and combinations can change based on evolving evidence. Your treating team can confirm the exact reason Capnat is recommended for you.
6) Dosing and treatment timing
Dosing for Capnat is usually based on body surface area (BSA) and the specific regimen. Schedules commonly follow patterns such as:
- Twice daily dosing for a set number of days, followed by a rest period
- Adjustments over cycles depending on blood counts, side effects, and tolerance
Always use the exact regimen on your treatment plan. Do not change the number of tablets, the timing, or the frequency without medical advice.
How to take Capnat tablets
- Swallow tablets whole with water.
- If a dose is missed, follow your healthcare team’s advice (many protocols include specific guidance; do not “double up”).
- Keep treatment adherence consistent, but report side effects promptly—dose modifications may be needed.
Typical timing guidance (general)
Capecitabine is commonly taken within about 30 minutes after food. Your prescription label and instructions from your clinic/pharmacist will give the exact meal timing. Because regimens vary, use your personal instructions as the primary guide.
7) Food interactions and practical meal timing
Food has a meaningful effect on how capecitabine is absorbed. In general:
- Take Capnat after food to reduce variability in absorption.
- Consistency matters: Try to take each dose after similar meals day to day.
Meal timing tip: Many patients take morning and evening doses after breakfast and dinner. If you struggle with appetite or nausea, discuss meal strategies with your care team rather than skipping doses without guidance.
8) Alcohol interactions
There is no single universal rule that forbids alcohol for everyone on capecitabine, but alcohol can:
- Increase the risk of side effects such as nausea, vomiting, dizziness, and fatigue
- Worsen dehydration (important if diarrhoea occurs)
- Potentially affect liver stress and overall tolerance of chemotherapy
Practical approach: Many clinicians advise limiting or avoiding alcohol during treatment, especially if you experience diarrhoea, mouth sores, or significant fatigue. If you want to drink, discuss with your healthcare team to individualise advice.
9) Medicine interactions (including vitamins and supplements)
Capecitabine can interact with other medicines. Some interactions may be related to effects on:
- Blood clotting (if you take blood thinners)
- Bone marrow function (if other medicines suppress it)
- Gut absorption and metabolism
- Liver/kidney clearance
Tell your healthcare team if you use any of the following:
- Warfarin and other anticoagulants (blood thinners): may increase bleeding risk in some patients.
- Phenytoin (for seizures): may require monitoring.
- Allopurinol and other drugs affecting uric acid pathways: may need caution.
- Medicines that affect liver enzymes (some anti-fungals, antibiotics, antivirals): can influence drug metabolism.
- Other chemotherapy or radiotherapy: combination toxicity needs careful monitoring.
- Over-the-counter medicines and supplements: for example, herbal products can also interact.
What you can do
- Keep an up-to-date list of all medicines you take.
- Bring the list to appointments.
- Ask your pharmacist if any new medicine (even “natural” products) could interact with capecitabine.
10) Safety profile and side effects
Like all medicines, Capnat can cause side effects. Some side effects are common and manageable; others may require urgent medical attention or dose adjustments.
Common side effects
- Diarrhoea
- Nausea and sometimes vomiting
- Decreased appetite
- Fatigue
- Hand-foot syndrome (palmar-plantar erythrodysesthesia): redness, pain, swelling, or tingling on palms/soles
- Mouth sores (stomatitis)
- Changes in taste
- Low blood counts (anaemia, white blood cell reduction, and sometimes low platelets)
- Skin changes
Serious side effects (seek urgent medical advice)
- Severe diarrhoea, especially if you feel weak, dizzy, or cannot keep fluids down
- Signs of infection (fever, chills, sore throat) if blood counts are low
- Severe mouth sores leading to dehydration or inability to eat
- Breathing problems or chest pain
- Severe allergic reactions (swelling, hives, trouble breathing)
- Bleeding or unusual bruising (especially if on blood thinners)
Important: Contact your oncology team promptly if side effects occur. They can advise whether you need supportive medication, hydration, or treatment adjustments.
Monitoring during treatment
To keep you safe, clinicians typically monitor:
- Blood counts (full blood count)
- Kidney function (creatinine/estimated GFR)
- Liver function (liver enzymes)
- Symptoms such as diarrhoea, mouth sores, and hand-foot reactions
11) Practical use tips (helping you manage everyday life)
Handling and storage
- Store tablets as directed on the packaging (typically at room temperature).
- Keep out of reach of children.
- Wash hands after handling tablets.
- Do not crush or break tablets unless your pharmacist explicitly instructs you to (follow your product instructions).
Managing diarrhoea and hydration
- Start early supportive measures when symptoms begin (your care team may recommend anti-diarrhoea medicine).
- Drink fluids regularly to prevent dehydration.
- Report diarrhoea promptly, especially if frequent or watery.
Reducing hand-foot syndrome discomfort
- Keep hands and feet moisturised with a suitable emollient.
- Avoid friction, heat exposure, and tight footwear.
- Let your team know if you develop redness, pain, or swelling—early management can help.
Oral care for mouth sores
- Maintain gentle oral hygiene.
- Use recommended mouth rinses if provided.
- Report painful sores early, as they may affect eating and hydration.
Fatigue and activity
- Plan rest periods and balance activity with recovery.
- Ask about supportive therapies (for example, managing anaemia) if fatigue is significant.
Pregnancy and contraception
Capecitabine may cause harm to an unborn baby. It is important to discuss contraception and family planning with your healthcare team before starting treatment and during therapy.
12) Dose modification and when treatment may be paused
Capecitabine dosing may be adjusted based on blood results and side effects. Dose modification decisions are made by your healthcare team according to clinical guidelines and your symptoms.
Common reasons for adjustment include:
- Severe diarrhoea
- Marked reduction in blood counts
- Severe hand-foot syndrome
- Significant mouth sores
- Kidney function changes
If you feel unwell, do not make dose changes yourself—contact your clinic for advice.
13) Alternative options
Depending on your cancer type, stage, and treatment plan, your clinician may consider alternative chemotherapy or targeted therapies. Alternatives can include other oral fluoropyrimidines (for example, 5-FU–based regimens using different delivery methods), combination chemotherapy protocols, or targeted and immunotherapy approaches.
Because options vary widely, ask your oncology team what alternatives apply to your diagnosis and whether they are suitable for your individual circumstances.
14) Market and legal context for Australia
In Australia, medicines like capecitabine are subject to regulatory and pharmaceutical supply frameworks. Availability and prescribing requirements depend on classification, specialist care pathways, and the individual product’s status.
How patients access treatment:
- Most cancer medicines are provided through structured oncology services.
- Special authority or reimbursement arrangements may apply to some medicines depending on the indication and eligibility criteria.
- Supply may be coordinated through pharmacies and treatment centres.
For the most current availability and subsidy information, you can also ask your pharmacist or check Australian health resources relevant to medicines coverage.
15) Recent guidance and clinical updates (general)
Oncology practice evolves as new evidence emerges. Recent areas of focus in fluoropyrimidine chemotherapy commonly include:
- Early recognition and prompt treatment of diarrhoea to reduce complications
- Prevention/early management of hand-foot syndrome
- Dose adjustments based on renal function and tolerability
- Close monitoring of blood counts during cycles
Your healthcare team may use updated dosing schedules or supportive care protocols depending on guideline recommendations and your personal risk factors.
16) Delivery and availability (Australia)
As an oral medicine, Capnat tablets may be supplied by participating pharmacies and delivered to eligible locations where permitted. Availability can vary by strength and packaging size.
What to expect when ordering:
- Stock status may change—if not immediately available, pharmacies may offer ordering timelines.
- Processing and delivery times depend on location and courier services.
- Check that the name, strength, and quantity match your treatment schedule.
Storage on arrival: Keep tablets in their original packaging, stored as directed, and out of reach of children.
17) Capnat FAQ
Is Capnat the same as capecitabine?
Yes. Capnat is a brand name that contains capecitabine, the active medicine.
How long does it take to start working?
People may begin to experience benefits at different times, and this depends on the cancer type and regimen. Your oncology team will monitor response using clinical assessments and imaging or blood tests as appropriate.
What happens if I miss a dose?
Missed-dose advice depends on the specific schedule. Contact your healthcare team or pharmacist for guidance. In general, you should not double up without instructions.
Should I take Capnat with water?
Yes. Swallow the tablets with a glass of water, and take them after food as instructed.
Can I take Capnat if I have kidney problems?
Kidney function affects medicine elimination. Your doctor may adjust the dose or monitoring frequency if you have reduced kidney function.
Can I drive while taking Capnat?
Some people experience fatigue, dizziness, or weakness. If you feel unwell, avoid driving and operating machinery until you know how Capnat affects you.
What should I do if I develop diarrhoea?
Report diarrhoea early. Follow your oncology team’s instructions for anti-diarrhoea measures and hydration. Seek urgent advice if diarrhoea is severe, persistent, or you feel dehydrated.
How can I reduce hand-foot syndrome risk?
Moisturise regularly, avoid friction and heat on hands and feet, wear comfortable footwear, and notify your team promptly if symptoms start.
Are herbal products safe with Capnat?
Some herbal products may affect metabolism or increase side effect risk. Check with your pharmacist or oncology team before using supplements.
Can I drink alcohol during treatment?
Limiting or avoiding alcohol is commonly recommended, especially if you have nausea, diarrhoea, dehydration, or significant fatigue. Discuss your situation with your healthcare team.
18) Key safety reminders
- Follow your exact dosing schedule and meal timing instructions.
- Report side effects early, particularly diarrhoea, fever/infection symptoms, and hand-foot syndrome.
- Keep your medication list updated for interaction checks.
- Stay hydrated and seek urgent help if you cannot keep fluids down.
- Do not change doses without advice from your healthcare team.
If you have questions about Capnat availability, dosing schedule, or how to manage side effects, your pharmacist and oncology team can provide support tailored to your regimen.

